信号通路调控上皮间质转化抑制乳腺癌转移的研究探索
Research Exploration on the Regulation of Epithelial-Mesenchymal Transition by Signaling Pathways to Inhibit Breast Cancer Metastasis
DOI: 10.12677/hjbm.2025.155104, PDF,    科研立项经费支持
作者: 刘 喆, 徐晓剑, 朱智健, 阮 越, 袁鑫楠, 石 莹, 宋 冬*:南京医科大学康达学院,江苏 连云港
关键词: 乳腺癌EMTWnt/βcateninTGFβ/SmadGSK3β/SnailBreast Cancer EMT Wnt/β-Catenin TGFβ/Smad GSK3β/Snail
摘要: 乳腺癌,这一学术领域内被广泛研究的恶性肿瘤,作为严重威胁女性健康的疾病,其进展与上皮间质转化(EMT)密切相关。EMT通过多层次调控网络驱动肿瘤侵袭转移,其中TGFβ/Smad通路呈现早期抑制、晚期激活EMT的时序性调控特征,与Wnt/β-catenin通路形成动态互作。AKT/GSK3β/Snail轴通过磷酸化级联调控转录因子,CXCL3/CXCR2轴经自/旁分泌激活下游信号,协同构建多维EMT调控体系。本研究系统解析上述核心通路的分子互作网络,阐明关键效应因子的生化机制及时空动态规律,旨在为乳腺癌早期分子标志物筛选及靶向治疗提供理论支撑,推动基于EMT节点干预的新型诊疗策略开发。
Abstract: Breast cancer, a malignant tumor widely studied in the academic field, as a disease seriously threatening women’s health, its progression is closely related to epithelial-mesenchymal transition (EMT). EMT drives tumor invasion and metastasis through a multi-level regulatory network. Among them, the TGFβ/Smad pathway shows the sequential regulatory characteristics of early inhibition and late activation of EMT, and forms a dynamic interaction with the Wnt/β-catenin pathway. The AKT/GSK3β/Snail axis regulates transcription factors through a phosphorylation cascade, while the CXCL3/CXCR2 axis activates downstream signals through autocrine/paracrine secretion, jointly constructing a multi-dimensional EMT regulatory system. This study systematically analyzed the molecular interaction networks of the above-mentioned core pathways, clarified the biochemical mechanisms and spatiotemporal dynamic laws of key effect factors, aiming to provide theoretical support for the screening of early molecular markers and targeted therapy of breast cancer, and promote the development of new diagnosis and treatment strategies based on EMT node intervention.
文章引用:刘喆, 徐晓剑, 朱智健, 阮越, 袁鑫楠, 石莹, 宋冬. 信号通路调控上皮间质转化抑制乳腺癌转移的研究探索[J]. 生物医学, 2025, 15(5): 975-982. https://doi.org/10.12677/hjbm.2025.155104

参考文献

[1] Liu, R. and Liu, Q. (2021) Multivariate Saturation Treatment of Malignant Tumor. Asian Journal of Surgery, 44, 1. [Google Scholar] [CrossRef] [PubMed]
[2] Manfioletti, G. and Fedele, M. (2023) Epithelial-Mesenchymal Transition (EMT). International Journal of Molecular Sciences, 24, Article No. 11386. [Google Scholar] [CrossRef] [PubMed]
[3] Song, C. and Zhou, C. (2021) HOXA10 Mediates Epithelial-Mesenchymal Transition to Promote Gastric Cancer Metastasis Partly via Modulation of TGFB2/Smad/METTL3 Signaling Axis. Journal of Experimental & Clinical Cancer Research, 40, Article No. 62. [Google Scholar] [CrossRef] [PubMed]
[4] Zhao, Y., Guo, C., Zeng, L., Li, J., Liu, X., Wang, Y., et al. (2022) Mesenchymal Stem Cells Ameliorate Fibrosis by Enhancing Autophagy via Inhibiting Galectin-3/Akt/mTOR Pathway and by Alleviating the EMT via Inhibiting Galectin-3/Akt/GSK3β/Snail Pathway in NRK-52E Fibrosis. International Journal of Stem Cells, 16, 52-65. [Google Scholar] [CrossRef] [PubMed]
[5] Rubtsova, S.N., Zhitnyak, I.Y. and Gloushankova, N.A. (2021) Dual Role of E-Cadherin in Cancer Cells. Tissue Barriers, 10, Article ID: 2005420. [Google Scholar] [CrossRef] [PubMed]
[6] Peng, Y., Wang, Y., Zhou, C., Mei, W. and Zeng, C. (2022) PI3K/Akt/mTOR Pathway and Its Role in Cancer Therapeutics: Are We Making Headway? Frontiers in Oncology, 12, Article ID: 819128. [Google Scholar] [CrossRef] [PubMed]
[7] Peng, D., Fu, M., Wang, M., Wei, Y. and Wei, X. (2022) Targeting TGF-β Signal Transduction for Fibrosis and Cancer Therapy. Molecular Cancer, 21, Article No. 104. [Google Scholar] [CrossRef] [PubMed]
[8] Moreau, J.M., Velegraki, M., Bolyard, C., Rosenblum, M.D. and Li, Z. (2022) Transforming Growth Factor-β1 in Regulatory T Cell Biology. Science Immunology, 7, eabi4613. [Google Scholar] [CrossRef] [PubMed]
[9] Huang, Z., Yu, P. and Tang, J. (2020) Characterization of Triple-Negative Breast Cancer MDA-MB-231 Cell Spheroid Model. OncoTargets and Therapy, 13, 5395-5405. [Google Scholar] [CrossRef] [PubMed]
[10] Zhou, L., Jiang, J., Huang, Z., Jin, P., Peng, L., Luo, M., et al. (2022) Hypoxia-Induced lncRNA STEAP3-AS1 Activates Wnt/β-Catenin Signaling to Promote Colorectal Cancer Progression by Preventing m6A-Mediated Degradation of STEAP3 mRNA. Molecular Cancer, 21, Article No. 168. [Google Scholar] [CrossRef] [PubMed]
[11] Piotrowska, A., Rojewska, E., Pawlik, K., Kreiner, G., Ciechanowska, A., Makuch, W., et al. (2019) Pharmacological Blockade of Spinal CXCL3/CXCR2 Signaling by NVP CXCR2 20, a Selective CXCR2 Antagonist, Reduces Neuropathic Pain Following Peripheral Nerve Injury. Frontiers in Immunology, 10, Article No. 2198. [Google Scholar] [CrossRef] [PubMed]
[12] Li, W., Wu, J., Jia, Q., Shi, Y., Li, F., Zhang, L., et al. (2024) PD-L1 Knockdown Suppresses Vasculogenic Mimicry of Non-Small Cell Lung Cancer by Modulating ZEB1-Triggered EMT. BMC Cancer, 24, Article No. 633. [Google Scholar] [CrossRef] [PubMed]
[13] Pavón-Romero, G.F., Parra-Vargas, M.I., Ramírez-Jiménez, F., Melgoza-Ruiz, E., Serrano-Pérez, N.H. and Teran, L.M. (2022) Allergen Immunotherapy: Current and Future Trends. Cells, 11, Article No. 212. [Google Scholar] [CrossRef] [PubMed]
[14] García de Herreros, A. and Duñach, M. (2019) Intracellular Signals Activated by Canonical Wnt Ligands Independent of GSK3 Inhibition and β-Catenin Stabilization. Cells, 8, Article No. 1148. [Google Scholar] [CrossRef] [PubMed]
[15] Yehia, L., Keel, E. and Eng, C. (2020) The Clinical Spectrum of PTEN Mutations. Annual Review of Medicine, 71, 103-116. [Google Scholar] [CrossRef] [PubMed]